IndraLab

Statements


Cas9 inhibits CYLD. 1 / 1
| 1

reach
"Interestingly, CRISPR/Cas9-mediated CYLD activation reduced the ubiquitination of NOX4 in LPS-stimulated BMMs (Fig. 4E)."